baber/WOPTO huggingface dataset:
Patent NZ-307274-A (NZ)
Title: Apparatus and method for reducing the pressure in a volatile organic chemical tank
Inventor: NANAJI SEIFOLLAH
IPC: B01D53/22
Filed: 1996-05-10
Abstract: Apparatus is provided for reducing the pressure in a volatile organic chemical (VOC) tank ullage (11) whilst minimising emissions of VOC vapours into the atmosphere. The apparatus comprises a separation module (44) having an inlet (48) for receiving vapours from the tank, an outlet (42) connected to vent pipe (21) for depleted/retentate and an outlet (46) for permeate separated from inlet (48) and outlet (42) by a membrane (18) permeable to VOC's. A pump (19) draws VOC's through the membrane whilst a vapour extractor (17) causes vapour from the ullage (11) to flow across the membrane (18). The flow of vapour across the membrane is controlled by controller (45) in dependance, at least in part, on the pressure sensed in the underground tank by sensor (23), and the concentration of VOC's in vent pipe (21) detected by VOC detector (24). The vapour flow is controlled such as to act to minimise emissions by maximising residence time in proximity to the membrane (18).
Patent NZ-315688-A (NZ)
Title: Plant protection composition containing one or more water soluble active materials and one or more polyalkoxylated amidoamines
Inventor: GUBELMANN ISABELLE
IPC: A01N57/20
Filed: 1996-08-02
Abstract: PCT No. PCT/FR96/01230 Sec. 371 Date Jan. 30, 1998 Sec. 102(e) Date Jan. 30, 1998 PCT Filed Aug. 2, 1996 PCT Pub. No. WO97/05779 PCT Pub. Date Feb. 20, 1997A composition containing, as active ingredient, one or more water soluble plant protection active materials and further containing an effective amount of one or more polyalkoxylated amidoamines of average formula (1) or (2), wherein all R1, which are the same or different, are a straight or branched C2-C22 alkyl or alkenyl hydrocarbon group, cycloalkyl or alkylaryl, all R2, which are the same or different, are hydrogen or a C1-C4 alkyl radical, and p, q, r, s and t, which are the same or different, are integers that can be zero, such that p+q is 1-20 and r+s+t is 1-20. Applications of said composition as a herbicide, a fungicide or a fertilizer are also described.
Patent NZ-330832-A (NZ)
Title: 5-heterocyclyl-alkyl-3-oxo-N-(heteroaryl or aryl)-pyrido[1,2-a]benzimidazole-4-carboxamide derivatives and medicaments
Inventor: REITZ ALLEN B
IPC: A61K31/435
Filed: 1998-06-29
Abstract: his compound of formula 1 or a pharmaceutically acceptable salt, solvate, hydrate, tautomer or rotomer thereof wherein: X is H, alkyl, halo, perfluoroalkyl, OH, alkoxy, dialkylamino, alkoxycarbonyl or alkylthio; R is an optionally substituted -(CH)2-heterocycle as defined in the specification and Ar is optionally substituted phenyl is claimed. A pharmaceutical composition containing a compound of formula 1 useful in the treatment of central nervous system disorders is claimed.
Patent NZ-331890-A (NZ)
Title: A self actuating top hung water control gate including a ballast tank
Inventor: TOWNSHEND PETER DOUGLAS
IPC: E02B7/42
Filed: 1997-02-12
Abstract: water control gate assembly comprises a self-actuating top-hung gate for controlling the flow of water in a waterway. The gate is pivotably mounted on a pair of piers located above and upstream of the gate for allowing the gate to pivot between a closed position and an open position in which water flows beneath the gate. The gate includes a ballast tank having an upstream inlet for charging the ballast tank and a downstream outlet for discharging the ballast tank. The upstream inlet is arranged to start charging the ballast tank with water in the event of the upstream water level reaching a first lower level. The downstream outlet is arranged to start discharging the ballast tank in the event of the upstream water level reaching a second upper level, with the ingress of water into the ballast tank between the first and second levels progressively increasing the closing moment of the gate and maintaining it closed against the progressively increasing opening moment of upstream water pressure against the gate.
Patent NZ-332034-A (NZ)
Title: Process for manufacture of a porous polymer and its use as an ophthalmic device or lens
Inventor: CHAOUK HASSAN
IPC: C08F290/06
Filed: 1997-03-20
Abstract: A process for the production of a porous polymer is claimed comprising the steps of: i) forming a mixture comprising a polymerizable component and a polar organic solvent selected from short chain alcohol, amines, ethers, nitriles, carboxylic acids, ketones and mixtures thereof wherein the polymerizable component comprises at least one macromonomer having at least one perfluoropolyether unit; ii) polymerizing said mixture wherein immediately after the polymerization of said mixture at least a substantial proportion of the organic solvent is in the form of a discrete phase and wherein the discrete organic solvent phase forms an interpenetrating network throughout the mixture or is dispersed throughout the mixture; and iii) removing the discrete organic solvent phase.
Patent NZ-333057-A (NZ)
Title: Metering device for seed, using pair of parallel rollers with soft resilient surfaces
Inventor: LARSEN FREDERICK JOHN
IPC: A01C7/16
Filed: 1998-11-27
Abstract: Particulate material, such as seed 30, falls directly into the nip between rollers 13, 13a rotating on horizontal shafts 21, 22.  One roller at least has a surface made of soft resilient material and the surfaces of the rollers are in contact at the nip. At least one of the shafts is driven to rotate the corresponding roller in a predetermined direction to meter the seed through the rollers at a predetermined rate.
Patent NZ-333641-A (NZ)
Title: Electric room heater, oil-filled radiator within grilled casing, radiator has expansion chamber
Inventor: NAUGHTON MARTIN LAWRENCE
IPC: F24H3/00
Filed: 1997-07-11
Abstract: A space heater is disclosed, comprising a housing, a heat source within the housing and a plurality of openings to allow the convection of air through the housing, in which:the heat source comprises a pair of panels defining between them a closed compartment, a liquid within and partially filling the compartment and an electrical heating element extending within the compartment, substantially parallel to the panels and in thermal contact with the liquid;the compartment is sub-divided into a lower liquid chamber and an upper expansion chamber and the cross-sectional area of the liquid chamber where it meets the expansion chamber is less than that of the expansion chamber; andthe openings in the housing allow radiant heat from the heat source to escape from the housing.In further embodiments, the lower liquid chamber contains liquid at room temperature, but the upper expansion chamber does not.
Patent NZ-337480-A (NZ)
Title: Inhalation device with transparent window on storage compartment, and indicating wheel being visible
Inventor: DAGSLAND ALLAN
IPC: A61M15/00
Filed: 1998-03-13
Abstract: An inhaler is disclosed for administering powder by inhalation and a method of constructing the same, the inhaler comprising: an inhaler body (6) having an opening (10) therein; an indicating wheel (42) disposed in the inhaler body (6) for providing an indication as to the usage of the inhaler, the indicating wheel (42) being disposed such that at least part thereof is visible through the opening (10) and so as to be rotatable in a diametrical plane containing the central axis of the inhaler body (6); a divider (14) substantially closing one end of the inhaler body (6); and a storage unit (26) disposed in the inhaler body (6), the storage unit (26) comprising a storage chamber (28) for storing powder for inhalation; characterized in that the inhaler body (6) and the divider (14) are formed as a single integral unit of an opaque material and in that the storage unit (26) is formed of a transparent material and has a portion (12) which substantially fills the opening (10).
Patent NZ-337976-A (NZ)
Title: Substituted phenyl derivatives, their preparation and use
Inventor: CHRISTOPHERSEN PALLE
IPC: C07C275/42
Filed: 1998-04-21
Abstract: A compound having formula (I) or a pharmaceutically acceptable salt thereof wherein: One of R1, R2 and R3 is a cyclic or heterocyclic acidic functional group having a pKa value below 8 or a group, which is convertible in vivo to such a group; R4, R5 and the two other substituents R1, R2 and R3 are each independently selected from hydrogen, alkyl, alkoxy, hydroxy, halogen, trifluoromethyl, cyano, nitro, amino, alkylamino, -COOR7, -NHSO2-alkyl, -SO2N(R7)2, -SO2OR7, -CO-R7, aryl, biphenyl, phenylamino, phenoxy or heteroaryl, wherein the aryl, biphenyl, phenylamino, phenoxy or heteroaryl group may be substituted one or more times with substituents selected from alkyl, hydroxy, alkoxy, halogen, trifluoromethyl, cyano, nitro, amino and alkylamino; aryl and heteroaryl; or R3 and R4 or R4 and R5 together form a cyclic structure; R7 is hydrogen, alkyl, amino or phenyl; Y is -CO-, -CS-, -SO2-, or -C(=N-R8)-, wherein R8 is hydrogen, alkyl, or cyano; X is -NH-, -CH2-NH-, or -SO2-NH-; Z is NR6, O, -CH=CH-, -N=CH-, or -CH=N-; R6 is hydrogen, or alkyl; R11- R15 are each independently selected from hydrogen, alkyl, alkoxy, hydroxy, halogen, trifluoromethyl, cyano, nitro, amino, alkylamino, -COOR7, -NHSO2-alkyl, -SO2N(R7)2, -SO2OR7, -CO-R7, aryl, biphenyl, phenylamino, phenoxy or heteroaryl, wherein the aryl, biphenyl, phenylamino, phenoxy or heteroaryl group may be substituted one or more times with substituents selected from alkyl, hydroxy, alkoxy, halogen, trifluoromethyl, cyano, nitro, amino and alkylamino; or one of R11 and R12, R12 and R13, R13 and R14 and R14 and R15 together form a cyclic structure. These compounds are useful in the treatment of sickle-cell anaemia.
Patent NZ-506241-A (NZ)
Title: Solid cyclodextrin flavor delivery systems
Inventor: REICHART GLENN
IPC: A23L27/00
Filed: 2000-08-09
Abstract: A process for the preparation of a solid cyclodextrin inclusion complex of an active compound comprising:  Dissolving cyclodextrin in a solvent;  Adding the active compound to the cyclodextrin solution;  Stirring and heating the resulting solution to form an inclusion complex;  Adding a solid to the inclusion complex solution;  Drying the solution to form a dry powder cyclodextrin inclusion complex containing the active compound in an amount of 1-20 percent by weight of the complex.
Patent NZ-507077-A (NZ)
Title: A vaccine comprising a bacterium that has an aroC/ompF/ompC combination mutation and optionally a mutation in a fourth gene
Inventor: CHATFIELD STEVEN NEVILLE
IPC: G01N33/74
Filed: 1999-03-25
Abstract: A bacterium attenuated by a non-reverting mutation in each of the aroC gene, the ompF gene and the ompC gene is described.  The bacterium is useful as a vaccine.  The bacterium may, for example, be an attenuated strain of E. coli useful in vaccination against diarrhoea.
Patent NZ-509827-A (NZ)
Title: Method, apparatus and support for testing poles
Inventor: DEUAR KRZYSZTOF JAN
IPC: E04H12/22
Filed: 1999-08-13
Abstract: A pole support for ground poles, such as telephone poles and power poles, is disclosed. The support can be driven into the ground next to the pole. It has a pair of spaced apart longitudinal end plates (51, 52) which are interconnected intermediate their ends by an intermediate plate (53). The end plates are spaced apart to allow the ground pole to pass at least partially between the end plates. Each end plate has a front longitudinal edge (54, 55) which, in use, is adjacent to the pole and a rear longitudinal edge (56, 57) which, in use, is directed away from the pole. The pole support has means to reduce sharp edges on the rear longitudinal edges. Also disclosed is a method for testing pole strength which comprises applying a load to the pole and either measuring its displacement or observing if it withstands the load. The amount of load applied to the pole and the degree of displacement it undergoes can be used to calculate the residual strength of the pole.
Patent NZ-509942-A (NZ)
Title: Media for water treatment
Inventor: JOENTGEN WINFRIED
IPC: C02F5/10
Filed: 1999-08-04
Abstract: A composition for water treatment is described.  The composition comprises: a) a biodegradable polymer with repeating succinyl units; b) a biocidal oxidizing agent selected from hydrogen peroxide, chlorine, bromine, chlorine dioxide, hypochlorite, hypobromite, ozone and their reaction products with water; and c) an unsubstituted or substituted amidosulphonic acid of the formula (I) wherein Z is a hydrogen, lithium, sodium, potassium, magnesium or calcium and R is a radical group.
Patent NZ-512679-A (NZ)
Title: Multi-component vaccine comprising at least two antigens from Haemophilus influenzae to protect against disease
Inventor: LOOSMORE SHEENA M
IPC: A61K39/116
Filed: 1999-12-15
Abstract: An immunogenic composition comprises at least two different antigens of Haemophilus influenzae. At least one of the antigens is an adhesin and the other antigen is not an adhesin.  Also described is a composition comprising a analog of Haemophilus influenzae Hin47 protein having a decreases protease activity, of which the activity is less than about 10% of natural Hin47, and a high molecular weight (HMW) protein of a strain of a non-typeable Haemophilus influenzae. The compositions can be used as a vaccine for conferring protection against disease caused by infection with Haemophilus influenzae including otitis media.
Patent NZ-514898-A (NZ)
Title: Method for treatment of containerized raw meat, poultry or fish by chilling
Inventor: MITCHELL JERRY L
IPC: A23L3/3409
Filed: 2000-05-24
Abstract: A method for treating a raw meat, poultry or fish product so as to stabilize and equilibrate pigment enzymes in the product is described.  The method involves: a) exposing the raw product to an anaerobic environment within a first sealed container; b) chilling the product to a temperature between 26-36oC; c) removing the product for the container; d) fabricating the product; and e) packaging the product in a second sealed gas impermeable container with a first gas.
Patent NZ-516206-A (NZ)
Title: Method for identifying properties of wood by infra-red or visible light
Inventor: THUMM ARMIN
IPC: G01N21/33
Filed: 2000-06-28
Abstract: A method for assessing logs before primary processing, or wood pieces before subsequent processing, in order to predict the behaviour of wood during subsequent processing, or to predict the performance of the wood in end use, comprising obtaining an infra-red or visible light reflectance spectra for the wood and predicting the behaviour of the wood during subsequent processing or predicting the performance of the wood after subsequent processing by reference to the infra-red or visible spectra obtained.
Patent NZ-526018-A (NZ)
Title: 8'4-'3-(5-fluoro-1H-indol-3-YL)propyl!-1-piperazinyl!-2-methyl-2H-1,4-benzoxazin -3(4H)-one methanesulfonate with high affinity for the dopamine D2 receptor and the seotonin reuptake site
Inventor: BAKKER CORNELIS
IPC: A61P25/22
Filed: 2002-02-19
Abstract: A phenylpiperazine derivative of formula (I), namely, 8-{4-[3-(5-fluoro-1H-indol-3-yl)-propyl]-piperazin-1-yl}-2-methyl- 4H-benzo[1,4]oxazin-3-one mesylate, useful in treating CNS disorders.
Patent NZ-527568-A (NZ)
Title: Salts of avermectins substituted in the 4"-position and having pesticidal properties
Inventor: PITTERNA THOMAS
IPC: C07H19/01
Filed: 2002-02-26
Abstract: A compound of formula (I) and, where applicable, E/Z isomers, E/Z isomeric mixtures and/or tautomers that are suitable as pesticides for controlling plant pests are disclosed, wherein X- is an anion; n is 1, 2, 3 or 4; R1 is C1-C12alkyl, C3-C8cycloalkyl; or C2-C12alkenyl; R2 is hydrogen, unsubstituted or substituted C1-C12alkyl or C2-C12alkenyl; R3 is hydrogen, unsubstituted or substituted C1-C12alkyl, C3-C12cycloalkyl, C2-C12alkenyl; or C2-C12alkynyl; or R2 and R3 together are an alkylene or alkenylene bridge or as defined in the specification; with the proviso that R1 is not sec-butyl or isopropyl when R2 is H and R3 is methyl; and, with the further proviso that X- is not a benzoate anion when R1 is sec-butyl and R3 and R3 are both H. Also disclosed is a process for the preparation of those compounds and their tautomers and the use thereof; pesticidal compositions in which the active ingredient has been selected from those compounds and their tautomers; and a process for the preparation of those compositions and the use thereof; intermediates, in free form or in salt form, for the preparation of those compounds and, where applicable, their tautomers, in free form or in salt form.
Patent NZ-536244-A (NZ)
Title: A gauge comprising a base, a pair of jaws, a sliding plate and markings for taking measurements related to spectacle
Inventor: BLACK BRIAN FREDERICK
IPC: G02C9/04
Filed: 2004-10-29
Abstract: A gauge having a base (1), a pair of jaws (6) , a sliding plate (5), and a marking or markings for determining dimensions or making measurements (21) of spectacle frames and/or lenses; the gauge is characterized in that when it is in use a spectacles' frame can be laid on the sliding plate and the jaws moved towards one another in unison to butt against opposite parts of the frame such that when the frame is in that position a marking on the sliding plate indicates a datum line (22) for the frame , and wherein the sliding plate can be slid when desired so that the marking can be used to test for symmetry at parts of the spectacles other than at the datum line.
Patent NZ-538135-A (NZ)
Title: New purine derivatives
Inventor: FISCHER PETER
IPC: A61K31/52
Filed: 2003-08-13
Abstract: Disclosed is a purine derivative of formula 1 wherein: One of R1 and R2 is methyl, ethyl or isopropyl, and the other is H; R3 and R4 are each independently H, branched or unbranched alkyl, or aryl, and wherein at least one of R3 and R4 is other than H; R5 is a branched or unbranched alkyl or cycloalkyl group, each of which may be optionally substituted with one or more OH groups; and R6, R7, R8 and R9 are independently H, halogen, NO2, OH, OMe, CN, NH2, COOH, CONH2 or SO2NH2. Compounds of the type disclosed are useful in the treatment of proliferative disorders such as cancer or leukaemia, glomerulonephritis, rheumatoid arthritis, psoriasis and chronic obstructive pulmonary disorder; viral disorders such as HCMV, HSV-1, HIV-1 and VZV; CNS disorders such as Alzheimer's disease or bipolar disorder; alopecia; stroke; diabetes; and neurodegenerative disorders such as neuronal apoptosis. Also disclosed a processes for preparing compounds of formula I.
Patent NZ-540045-A (NZ)
Title: Treatment for traumatic synovitis and damaged articular cartilage with chondroitin sulfate, N-acetyl D-glucosamine and hyaluronan
Inventor: MARCUM FRANK D
IPC: A61K31/70
Filed: 2003-10-16
Abstract: Disclosed is a composition adapted for parental administration for the treatment of traumatic synovitis and/or damaged articular cartilage of a diarthrodial joint in man or in animals, the composition comprising therapeutic amounts of: chondroitin sulfate; N-acetyl D-glucosamine; hyaluronan and in the absence of a separate analgesic agent.
Patent NZ-545450-A (NZ)
Title: Phenoxiacetic acid derivatives
Inventor: BONNERT ROGER VICTOR
IPC: C07C317/36
Filed: 2004-08-18
Abstract: Compounds of formula (I), wherein the substituents are as defined in the specification, are useful in the manufacture of medicaments for the treatment of respiratory diseases. Certain novel compounds of formula (I) are disclosed, as are processes for their preparation and intermediates for use therein.
Patent NZ-545886-A (NZ)
Title: Enhanced parimutuel wagering
Inventor: LANGE JEFFREY
IPC: H01L21/28
Filed: 2004-08-06
Abstract: Methods and systems for engaging in enhanced parimutuel wagering and gaming are provided. In one embodiment, different types of bets can be offered and processed in the same betting pool on an underlying event, such as a horse or dog race, a sporting event or a lottery, and the premiums and payouts of these different types of bets can be determined in the same betting pool, by configuring an equivalent combination of fundamental bets for each type of bet, and performing a demand-based valuation of each of the fundamental bets in the equivalent combination. In another embodiment, bettors can place bets in the betting pool with limit odds on the selected outcome of the underlying event. The bets with limit odds are not filled in whole or in part, unless the final odds on the selected outcome of the underlying event are equal to or greater than the limit odds.
Patent NZ-547644-A (NZ)
Title: A built in lamp with additional reflector
Inventor: ENGEL HARTMUT S
IPC: F21V7/00
Filed: 2004-11-26
Abstract: A built-in lamp comprising a holder 10 for securing in an installation surface 11, a bulb fitting and a reflector which consists at least of one first reflector region 7 which is followed in the direction of illumination by a second reflector region 7 which can be released from the first reflector region 7 to permit a change of the bulb, with the first reflector region 7 being made as an additional reflector and the second reflector region 7 being made as a direct light reflector, and wherein a reflector opening of the direct light reflector disposed in the direction of illumination defines a direct light discharge region 13 which is surrounded at least regionally by a diffuse light discharge region 2, wherein the diffuse light discharge region 2 is terminated by a plate which can be released, together with the direct light reflector 4 secured to it, from a housing or from a frame of the built-in lamp.
Patent NZ-549976-A (NZ)
Title: Naltrexone long acting formulations and methods of use
Inventor: EHRICH ELLIOT
IPC: A61K9/00
Filed: 2005-03-18
Abstract: Disclosed is the use of naltrexone in the manufacture of a medicament for the treatment of alcohol dependency wherein said medicament is administered parenterally as a long acting formulation to an individual wherein the serum AUC of naltrexone is at least about two times greater than that achieved by 50 mg/day oral administration. Also disclosed is the use of naltrexone in the manufacture of a medicament for treating alcohol dependency wherein said medicament is a long acting formulation comprising naltrexone administered parenterally in a dosage between about 160 mg to about 480 mg naltrexone every four weeks for a period of at least about 24 weeks wherein the individual has not used oral naltrexone within five days before said administration and wherein the individual is not co-administered alcohol.
Patent NZ-551543-A (NZ)
Title: Pyridine derivatives of alkyl oxindoles as 5-HT7 receptor active agents
Inventor: BARKOCZY JOZSEF
IPC: C07D401/04
Filed: 2005-05-10
Abstract: Disclosed are 3-alkyl indol-2-one derivatives of general Formula (I) which bind to 5-HT7 receptors and inhibit serotonin uptake, wherein R1 stands for hydrogen, halogen or alkyl; R2 and R3 represent hydrogen or alkyl; R4 represents hydrogen and R5 stands for a substituted phenyl moiety; or R4 and R5 form, together with the adjacent carbon atoms of the tetrahydropyridine ring, phenyl or a 5- or 6-membered heterocyclic ring containing sulphur as a heteroatom. Also disclosed is the use of an efficient amount of a pharmaceutical composition containing at least one of the above compounds or a pharmaceutically acceptable, organic or inorganic acid addition salt thereof for the manufacture of a medicament for the treatment or prophylaxis of central nervous system disorders, including depression, anxiety, compulsive disorder, panic disease, social phobia, schizophrenia, mood disorders, mania, mental decline, stroke, cell death in certain areas of the central nervous system, mental decline followed by cerebellar cell death, Alzheimer's disease, dementia, post-traumatic disease or stress disorder..